Profound Medical ( PROF ) entered into a definitive co-sales and co-marketing agreement with Siemens Healthineers ( SIEGY ) pursuant to which the companies will commercialize a new MRI-guided prostate therapy solution which combines Profound’s TULSA-PRO system and consumables with Siemens Healthineers’ Magnetom Free.Max magnetic resonance scanner. Subject to the completion of the compatibility process of TULSA-PRO and Magnetom Free.Max, the companies currently expect to initiate sales of the total prostate solution in 2025.
Don't Miss our Black Friday Offers:
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on PROF: